A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks

Trial Profile

A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Benzoyl peroxide/tretinoin (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Sol-Gel Technologies
  • Most Recent Events

    • 26 Mar 2018 According to a Sol-Gel Technologies media release, data from this trial was presented at the American Academy of Dermatology (AAD) Annual Meeting 2018.
    • 15 Feb 2018 According to a Sol-Gel Technologies media release, data will be presented at the 2018 American Academy of Dermatology (AAD) Annual Meeting
    • 03 Oct 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top